PubRank

S Kusne

Author PubWeight™ 69.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988 2.76
2 Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996 2.12
3 Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc 1991 1.75
4 Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995 1.59
5 Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 2006 1.55
6 Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review. Clin Infect Dis 1992 1.54
7 Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006 1.52
8 Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001 1.39
9 Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc 1990 1.30
10 De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001 1.30
11 Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center. Clin Infect Dis 1998 1.28
12 Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997 1.23
13 Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations. Antimicrob Agents Chemother 1993 1.18
14 Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis 1996 1.15
15 Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis 2002 1.14
16 Cryptococcal meningitis after liver transplantation. Transplantation 1996 1.08
17 CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1993 1.07
18 Cytomegalovirus disease in intestinal transplantation. Transplant Proc 1995 1.07
19 Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. Arch Surg 1997 1.05
20 The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc 1991 1.05
21 Transmission of infection with herpes simplex virus by renal transplantation. J Infect Dis 1987 1.03
22 The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis 1995 1.03
23 Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation 1996 1.02
24 Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava in a liver transplant recipient. Clin Infect Dis 1994 0.99
25 The radiology of pulmonary cryptococcosis in a tertiary medical center. J Thorac Imaging 2001 0.98
26 Impact of OKT3 Therapy on Cytomegalovirus and Herpes Simplex Virus Infections After Liver Transplantation. Transplant Proc 1988 0.97
27 Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg 1996 0.96
28 The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993 0.95
29 Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. Transplant Proc 1994 0.94
30 Self-limited Toxoplasma parasitemia after liver transplantation. Transplantation 1987 0.94
31 Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis 1997 0.94
32 The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore) 2001 0.93
33 Acute invasive sinusitis due to Trichoderma longibrachiatum in a liver and small bowel transplant recipient. Clin Infect Dis 1998 0.93
34 A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1994 0.93
35 Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipient. Transpl Infect Dis 2003 0.91
36 Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation 1994 0.91
37 Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant 2009 0.89
38 Relapsing bacteremia in patients with ventricular assist device: an emergent complication of extended circulatory support. Ann Thorac Surg 2001 0.88
39 The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis 2001 0.88
40 Cutaneous legionellosis: case report and review of the medical literature. Transpl Infect Dis 2014 0.87
41 Fluconazole therapy in transplant recipients receiving FK506. Transplantation 1994 0.86
42 Acute respiratory failure associated with pulmonary cryptococcosis in non-aids patients. Chest 2001 0.86
43 Diagnosis of cytomegalovirus infections by shell vial assay and conventional cell culture during antiviral prophylaxis. J Clin Microbiol 1994 0.85
44 Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation 2000 0.84
45 Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava. Clin Infect Dis 1996 0.84
46 The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis 2002 0.84
47 The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995 0.84
48 Candida infections in solid organ transplantation. Am J Transplant 2013 0.83
49 The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation. Transfusion 1993 0.83
50 Infectious complications after human small bowel transplantation. Transplant Proc 1992 0.82
51 Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients. Transpl Int 1994 0.82
52 Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation 2000 0.80
53 Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen--Chaetomium atrobrunneum: case report. Neurosurgery 1999 0.80
54 Concurrent pulmonary Aspergillus fumigatus and mucor infection in a cardiac transplant recipient: a case report. Transplant Proc 2012 0.79
55 Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation. Transplant Proc 1995 0.79
56 Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. Transplant Proc 1993 0.79
57 Fulminant hepatitis due to human adenovirus. Infection 2013 0.79
58 Adenovirus hepatitis in the adult allograft liver. Transplantation 1997 0.78
59 Leuconostoc bacteremia after liver transplantation: another cause of vancomycin resistant gram-positive infection. Clin Transplant 1997 0.78
60 Cavitary pneumonia due to Rhodococcus equi in a heart transplant recipient. Transpl Infect Dis 2003 0.77
61 Sterility of bile in multiple-organ donors. Transplantation 1990 0.76
62 Infections after liver transplantation: risk factors and prevention. Transplant Proc 1991 0.76
63 Successful treatment of zygomycosis of the paranasal sinuses with surgical debridement and amphotericin B colloidal dispersion. Am J Otolaryngol 1993 0.76
64 Vanishing bile duct syndrome after liver transplantation: alloreactivity or viral reactivity? Transplant Proc 1995 0.76
65 Liver transplantation and related infections. Semin Respir Infect 1993 0.76
66 Candida albicans osteomyelitis in a liver transplant recipient: a case report and review of the literature. Transplantation 1996 0.76
67 CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc 1991 0.75
68 Intestinal transplantation in 31 adults. Transplant Proc 1996 0.75
69 Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients. Transplant Proc 1995 0.75
70 A tuberculosis outbreak in a renal transplant program. Transplant Proc 1991 0.75
71 Effect of CMV serology on outcome after clinical intestinal transplantation. Transplant Proc 1996 0.75
72 Anomalous pattern of IgG antibody response to primary cytomegalovirus infection after solid organ retransplantation. Transplantation 1995 0.75
73 Coccidioidomycosis masked by symptoms of end-stage liver disease in transplant candidates. Transpl Infect Dis 2007 0.75
74 Initial studies with FK506 in renal transplantation. Cleve Clin J Med 1991 0.75
75 Detection of cytomegalovirus in formalin-fixed paraffin-embedded donor, native and allograft liver tissue using a multiplex polymerase chain reaction-liquid hybridization assay. Mod Pathol 1994 0.75
76 Nocardia prostatitis in a small intestine transplant recipient. Transpl Infect Dis 2003 0.75
77 Kluyvera co-infection in two solid organ transplant recipients: an emerging pathogen or a colonizer bystander? Transpl Infect Dis 2007 0.75
78 Cytomegalovirus infection of the native ureter after liver-kidney transplantation. Urology 1999 0.75
79 Disseminated histoplasmosis in a patient after orthotopic liver transplantation. Clin Transplant 1998 0.75
80 Legionellosis in a lung transplant recipient obscured by cytomegalovirus infection and Clostridium difficile colitis. Transpl Infect Dis 2002 0.75